IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Savient Pharmaceuticals Inc

CUSIP: 80517QAA8 | 18 institutional holders

Quarters

Q1 2014Q4 2013Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2014

Ameriprise Financial Inc300,000
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Ameriprise Financial Inc
300,000$30.0%CoreMediumMinneapolis, MN2014-05-14